Literature DB >> 15965143

Mortality in children from influenza and respiratory syncytial virus.

Douglas M Fleming1, Rachel S Pannell, Kenneth W Cross.   

Abstract

STUDY
OBJECTIVE: To quantify mortality attributable to influenza and respiratory syncytial virus (RSV) infection in children. DESIGN AND METHODS: Comparison of death rates (all cause and certified respiratory) in England over winters 1989/90 to 1999/00 during and outside influenza and RSV circulation periods. Virus active weeks were defined from clinical and virological surveillance data. Excess deaths associated with weeks of either influenza or RSV activity over virus non-active weeks were estimated in each winter for age groups 1-12 months, 1-4, 5-9, and 10-14 years. The estimate obtained was allotted to influenza and RSV in the proportion derived from independent separate calculations for each virus. MAIN
RESULTS: Average winter respiratory deaths attributed to influenza in children 1 month-14 years were 22 and to RSV 28; and all cause deaths to influenza 78 and to RSV 79. All cause RSV attributed deaths in infants 1-12 months exceeded those for influenza every year except 1989/90; the average RSV and influenza attributed death rates were 8.4 and 6.7 per 100 000 population respectively. Corresponding rates for children 1-4 years were 0.9 and 0.8 and for older children all rates were 0.2 or less, except for an influenza rate of 0.4 in children 10-14 years.
CONCLUSIONS: Influenza and RSV account for similar numbers of deaths in children. The impact varies by winter and between age groups and is considerably underestimated if analysis is restricted to respiratory certified deaths. Summing the impact over the 11 winters studied, compared with influenza RSV is associated with more deaths in infants less than 12 months, almost equal numbers in children 1-4 years, and fewer in older children. Improved information systems are needed to investigate paediatric deaths.

Entities:  

Mesh:

Year:  2005        PMID: 15965143      PMCID: PMC1757088          DOI: 10.1136/jech.2004.026450

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  14 in total

1.  The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.

Authors:  D M Fleming; M Zambon; A I Bartelds; J C de Jong
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  Influenza vaccine--outmaneuvering antigenic shift and drift.

Authors:  John Treanor
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

3.  Contribution of RSV to bronchiolitis and pneumonia-associated hospitalizations in English children, April 1995-March 1998.

Authors:  B Müller-Pebody; W J Edmunds; M C Zambon; N J Gay; N S Crowcroft
Journal:  Epidemiol Infect       Date:  2002-08       Impact factor: 2.451

Review 4.  Respiratory syncytial virus: an underestimated cause of respiratory infection, with prospects for a vaccine.

Authors:  N S Crowcroft; F Cutts; M C Zambon
Journal:  Commun Dis Public Health       Date:  1999-12

5.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution.

Authors:  L Simonsen; M J Clarke; L B Schonberger; N H Arden; N J Cox; K Fukuda
Journal:  J Infect Dis       Date:  1998-07       Impact factor: 5.226

6.  The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter.

Authors:  D M Fleming
Journal:  Commun Dis Public Health       Date:  2000-03

7.  "A study of excess mortality during influenza epidemics in the United States, 1968-1976".

Authors:  W H Barker; J P Mullooly
Journal:  Am J Epidemiol       Date:  1982-03       Impact factor: 4.897

8.  Impact of influenza and respiratory syncytial virus on mortality in England and Wales from January 1975 to December 1990.

Authors:  K G Nicholson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

9.  Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study.

Authors:  M C Zambon; J D Stockton; J P Clewley; D M Fleming
Journal:  Lancet       Date:  2001-10-27       Impact factor: 79.321

10.  Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children.

Authors:  John V Williams; Paul A Harris; Sharon J Tollefson; Lisa L Halburnt-Rush; Joyce M Pingsterhaus; Kathryn M Edwards; Peter F Wright; James E Crowe
Journal:  N Engl J Med       Date:  2004-01-29       Impact factor: 91.245

View more
  43 in total

Review 1.  Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.

Authors:  Yechiel Becker
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

2.  Student column: Using academic detailing to improve childhood influenza vaccination rates in San Diego.

Authors:  Evelyn Ly; K Michael Peddecord; Wendy Wang; Kimberly Ralston; Mark H Sawyer
Journal:  Public Health Rep       Date:  2015 Mar-Apr       Impact factor: 2.792

3.  [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment].

Authors:  Sara Boccalini; Angela Bechini; Maddalena Innocenti; Gino Sartor; Federico Manzi; Paolo Bonanni; Donatella Panatto; Piero Luigi Lai; Francesca Zangrillo; Emanuela Rizzitelli; Mariasilvia Iovine; Daniela Amicizia; Chiara Bini; Andrea Marcellusi; Francesco Saverio Mennini; Alessandro Rinaldi; Francesca Trippi; Anna Maria Ferriero; Giovanni Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2018-05-30

Review 4.  Bronchiolitis.

Authors:  Thomas Bourke; Michael Shields
Journal:  BMJ Clin Evid       Date:  2011-04-11

5.  CpG in Combination with an Inhibitor of Notch Signaling Suppresses Formalin-Inactivated Respiratory Syncytial Virus-Enhanced Airway Hyperresponsiveness and Inflammation by Inhibiting Th17 Memory Responses and Promoting Tissue-Resident Memory Cells in Lungs.

Authors:  Lei Zhang; Hongyong Li; Yan Hai; Wei Yin; Wenjian Li; Boyang Zheng; Xiaomin Du; Na Li; Zhengzheng Zhang; Yuqing Deng; Ruihong Zeng; Lin Wei
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

6.  Heterogeneity in Estimates of the Impact of Influenza on Population Mortality: A Systematic Review.

Authors:  Li Li; Jessica Y Wong; Peng Wu; Helen S Bond; Eric H Y Lau; Sheena G Sullivan; Benjamin J Cowling
Journal:  Am J Epidemiol       Date:  2018-02-01       Impact factor: 4.897

7.  R848 or influenza virus can induce potent innate immune responses in the lungs of neonatal mice.

Authors:  Spyridon Makris; Cecilia Johansson
Journal:  Mucosal Immunol       Date:  2020-06-23       Impact factor: 7.313

8.  Recombinant simian varicella viruses expressing respiratory syncytial virus antigens are immunogenic.

Authors:  Toby M Ward; Vicki Traina-Dorge; Kara A Davis; Wayne L Gray
Journal:  J Gen Virol       Date:  2008-03       Impact factor: 3.891

Review 9.  Bronchiolitis.

Authors:  Juan Manuel Lozano
Journal:  BMJ Clin Evid       Date:  2007-10-10

Review 10.  Lessons from 40 years' surveillance of influenza in England and Wales.

Authors:  D M Fleming; A J Elliot
Journal:  Epidemiol Infect       Date:  2007-11-30       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.